Search
Surgery Partners Inc
SGRYAdd to Watchlist
15.400USD
-0.500-3.14%
Close 07-31 16:00（ET）Quotes delayed by 15 min
2.01BMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-07-31The current earnings forecast score of Surgery Partners Inc is 8.00, ranking 29 out of 75 in the Healthcare Providers & Services industry. The average price target is 28.00, with a high of 36.00 and a low of 18.00.
Analyst Rating
Based on
12
analysts
Buy
Current Rating
19.100
Target Price
+24.03%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
58
Total
9
Median
10
Average
Company name
Ratings
Analysts
Surgery Partners Inc
SGRY
12
CVS Health Corp
CVS
29
Teladoc Health Inc
TDOC
27
HCA Healthcare Inc
HCA
26
Natera Inc
NTRA
24
Tenet Healthcare Corp
THC
23
1
2
3
...
12
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Surgery Partners Inc's expected revenue for the next quarter?
Surgery Partners Inc's expected revenue is 830.37M.
What is Surgery Partners Inc's price target?
Analysts forecast that Surgery Partners Inc's price target is USD 28.00, with the highest forecast at USD 36.00 and the lowest forecast at USD 18.00.
How have Surgery Partners IncSGRY's recent earnings per share performed?
The market expectation was USD -0.28, while Surgery Partners IncSGRY's earnings per share (EPS) for the previous quarter was USD -0.12. EPS for the next quarter is expected at USD 0.06.
What is the analyst rating for Surgery Partners Inc?
Based on the ratings of Surgery Partners Inc's stock from 12 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.